CD200 and B-cell chronic lymphocytic leukemia: Importantly, CD200 is expressed in a wide spectrum of cancers, including chronic lymphocytic leukemia (CLL) [20], multiple myeloma [21], acute myeloid leukemia [22], melanoma [23], ovarian tumors [24], metastatic small cell carcinoma [25], and glioblastoma [10].